SUPT7L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.142600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.384400E-02
Normal-vs-Stage2
7.856100E-03
Normal-vs-Stage3
2.617800E-02
Normal-vs-Stage4
2.041800E-01
Stage1-vs-Stage2
9.968400E-01
Stage1-vs-Stage3
9.447800E-02
Stage1-vs-Stage4
4.545800E-01
Stage2-vs-Stage3
7.322000E-02
Stage2-vs-Stage4
4.417400E-01
Stage3-vs-Stage4
7.403900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.108360E-02
Normal-vs-AfricanAmerican
9.474100E-02
Normal-vs-Asian
2.926400E-02
Caucasian-vs-AfricanAmerican
8.416800E-01
Caucasian-vs-Asian
4.866200E-01
AfricanAmerican-vs-Asian
8.046600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.175400E-03
Normal-vs-Female
1.577740E-02
Male-vs-Female
2.728800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.640220E-01
Normal-vs-Age(41-60Yrs)
1.286350E-02
Normal-vs-Age(61-80Yrs)
9.401300E-03
Normal-vs-Age(81-100Yrs)
1.314480E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.048600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.235800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.555800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.755900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.189360E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.706400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.083400E-03
Normal-vs-Daily Drinker
1.709860E-02
Normal-vs-Weekly Drinker
2.848100E-02
Normal-vs-Occasional Drinker
5.666400E-02
Normal-vs-Social Drinker
6.824200E-02
Non Drinker-vs-Daily Drinker
7.230000E-01
Non Drinker-vs-Weekly Drinker
5.740200E-01
Non Drinker-vs-Occasional Drinker
8.638300E-02
Non Drinker-vs-Social Drinker
1.996240E-02
Daily Drinker-vs-Weekly Drinker
8.173800E-01
Daily Drinker-vs-Occasional Drinker
2.020800E-01
Daily Drinker-vs-Social Drinker
6.074500E-02
Weekly Drinker-vs-Occasional Drinker
3.461000E-01
Weekly Drinker-vs-Social Drinker
1.205980E-01
Occasional Drinker-vs-Social Drinker
5.253200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.047000E-01
Normal-vs-Grade 2
6.618400E-01
Normal-vs-Grade 3
6.236800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.930600E-01
Grade 1-vs-Grade 3
3.289000E-01
Grade 1-vs-Grade 4
3.047000E-01
Grade 2-vs-Grade 3
2.632400E-01
Grade 2-vs-Grade 4
6.618400E-01
Grade 3-vs-Grade 4
6.236800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.883100E-03
Normal-vs-NonDiabetic
9.842700E-03
Diabetic-vs-NonDiabetic
1.419610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.289800E-02
Normal-vs-NoPancreatitis
7.104100E-03
Pancreatitis-vs-NoPancreatitis
7.196400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.014200E-02
Normal-vs-N1
9.755200E-03
N0-vs-N1
9.260600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.063700E-03
Normal-vs-TP53-NonMutant
4.005900E-02
TP53-Mutant-vs-TP53-NonMutant
8.658200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
